|
|
Volumn 9, Issue 6, 2008, Pages 421-422
|
|
Editorial: Therapeutic antibodies and derivatives: From the bench to the clinic
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ADALIMUMAB;
ALEFACEPT;
ALEMTUZUMAB;
ATLIZUMAB;
BASILIXIMAB;
BEVACIZUMAB;
CERTOLIZUMAB PEGOL;
CETUXIMAB;
DACLIZUMAB;
ECULIZUMAB;
EDRECOLOMAB;
EFALIZUMAB;
ETANERCEPT;
GEMTUZUMAB OZOGAMICIN;
IBRITUMOMAB TIUXETAN;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD28;
NATALIZUMAB;
NIMOTUZUMAB;
OMALIZUMAB;
PALIVIZUMAB;
PANITUMUMAB;
RANIBIZUMAB;
REDITUX;
RILONACEPT;
RITUXIMAB;
TGN 1412;
TOSITUMOMAB I 131;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ALLERGY;
ANALYTIC METHOD;
AUTOIMMUNE DISEASE;
BIOREACTOR;
BIOTECHNOLOGY;
CHO CELL;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SPECIFICITY;
DRUG STRUCTURE;
DRUG TARGETING;
EDITORIAL;
ESCHERICHIA COLI;
FINANCIAL MANAGEMENT;
GRAFT REJECTION;
HEART DISEASE;
HUMAN;
INFECTION;
MALIGNANT NEOPLASTIC DISEASE;
NONHUMAN;
ORGAN TRANSPLANTATION;
PHAGE DISPLAY;
PHYSICAL CHEMISTRY;
RHEUMATIC DISEASE;
STRUCTURE ACTIVITY RELATION;
TISSUE GROWTH;
TISSUE REPAIR;
TRANSGENIC MOUSE;
TREATMENT OUTCOME;
DRUG SCREENING;
IMMUNOLOGY;
IMMUNOTHERAPY;
MEDICAL RESEARCH;
METHODOLOGY;
ANTIBODIES, MONOCLONAL;
BIOMEDICAL RESEARCH;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
IMMUNOTHERAPY;
|
|
EID: 60849117560
PISSN: 13892010
EISSN: 18734316
Source Type: Journal
DOI: 10.2174/138920108786786420 Document Type: Editorial |
|
Times cited : (32)
|
|
References (0)
|
